Vernalis Vernalis has collaborated with a wide range of partners to enable some of the most challenging therapeutic targets Present and past collaborators include Servier, Pierre Fabre, Genentech and Lundbeck
About us - Vernalis “We collaborate with Vernalis on an integrated drug discovery project where Vernalis has delivered remarkable results against an historically “undruggable” target The team possesses a powerful blend of creativity and scientific rigor and have been superb colleagues to work with on a personal level
News Publications - Vernalis Find Us Vernalis (R D) Limited Granta Park Great Abington Cambridge CB21 6GB United Kingdom Follow Us Vernalis is a member of the HitGen group of companies
Our History - Vernalis The new three-year research collaboration combined Vernalis’ strengths in structure and biophysics-based methods with oncology expertise at Servier, to enable drug discovery related to several undisclosed proteins identified as potential therapeutic targets
Chemistry - vernalis. com Lee Walmsley has been with Vernalis since 2001 and, prior to that, was with Roche for 9 years Lee has led successful drug discovery projects in collaboration with our partners based in Europe, USA and Japan He is a champion of bringing new methodologies to our chemistry group
Research Case Studies - vernalis. com For further information about partnering with Vernalis, or to find out more about our capabilities or career opportunities
Biophysics and Structural Biology - vernalis. com Dr Lisa Baker joined Vernalis Research over twenty years ago, having previously completed a degree and PhD in Biophysics and a postdoctoral position in the York Structural Biology Laboratory She is the Senior Team Leader of the Protein Crystallography NMR groups
Pierre Fabre Laboratories and Vernalis announce a drug discovery . . . Castres, France and Cambridge UK, 25 September 2023 – Pierre Fabre Laboratories and Vernalis (R D) Ltd (“Vernalis”), a fully owned subsidiary of HitGen Inc , are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology targets
Careers - Vernalis Vernalis fosters a culture that values forging strong collaborations and creating a positive work atmosphere It’s a place where I’ve found valuable experiences in the realm of drug development but also colleagues to have a laugh with ”
Hox Therapeutics and Vernalis announce a drug discovery collaboration . . . Vernalis is a world leader in fragment and structure-based drug discovery with a record of progressing targets from concept to clinic Based in Cambridge, UK, we have generated development candidates across oncology, neurodegeneration, anti-infectives and inflammation, through global collaborations